Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Health official speaks out about row over drug critic

Nature volume 449, pages 952–953 (2007)Cite this article

Fresh light is shed on dispute over diabetes pill.

The former drug-company official who heads global health at the Bill and Melinda Gates Foundation has broken his silence over accusations of acting inappropriately eight years ago, when a physician raised questions about the safety of one of the company's drugs.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  1. Nissen, S. E. & Wolski, K. N. Engl. J. Med. 356, 2457–2471 (2007).

  2. Singh, S. et al. 298, 1189–1195 (2007).

Download references

Authors
  1. Meredith Wadman
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Nature Reviews Drug Discovery

Cardiovascular medicine

Related external links

Congressional Record transcript of Claypool-Yamada email exchange 12 September 2007

Tachi Yamada biography

John Buse

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wadman, M. Health official speaks out about row over drug critic. Nature 449, 952–953 (2007). https://doi.org/10.1038/449952b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/449952b

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing